Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detrusitol OAB Assessment Tool Validation
NCT00313924Phase 4Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tolterodine in overactive bladder (OAB), sponsored by Rambam Health Care Campus. Primary endpoint: Correlation between reduced urinary symptoms and a reduction of more than 10 points in the OAB-8 score at 1 month. Status: unknown.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00313924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313924.